CTRI/2020/12/029600已完成未知
A Clinincal study to assess the efficacy and safety of an ayurvedic polyherbal formulation in the management of flu like symptoms - FLUVA
Clinfound Clinical Research Services Pvt Ltd0 个研究点目标入组 30 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Suffering from fever in URTI up to 7 days with associated secondary symptoms
- •(which may or may not be present)
- •i.e., headache (Å?iroÅ?Å«la)
- •pain in joints and muscle (parbaveá¸?)
- •malaise-catarrh (staÄ«miá¹ya),
- •uneasy breathing (Å?vÄ?sa),
- •cough (kÄ?sa),
- •running nose (pratÄ«Å?yaya)
- •loss of appetite (arÅ«chi)
排除标准
- •Patients with temperature more than 390C (i.e., >102.20F), abnormal
- •pulmonary findings, pleuritis, pneumonia, bronchitis, using warfarin,
- •antibiotics and/or anti-inflammatory drugs, hypersensitivity to
- •NSAIDs, history of trauma, malignancy, diabetes mellitus, high blood
- •pressure, severe systemic and organ disorders, peptic ulcer syndrome,
- •bleeding tendency, major surgery and chronic fever (like malaria,
- •typhoid, tuberculosis etc.), pregnant and lactating females, patients
- •with alcoholism or who were heavy smokers ( >20 cigarettes a day)
研究者
相似试验
进行中（未招募）
1 期
Clinical study to evaluate the efficacy, safety and kinetics of Octagam® 10% for replacement therapy in Primary Immunodeficiency Diseases (PID) - NAPrimary Immundeficiency Diseases (PID)MedDRA version: 9.1 Level: LLT Classification code 10064859 Term: Primary immunodeficiency syndromeEUCTR2007-002611-27-GBOctapharma AG5
进行中（未招募）
1 期
Clinical study to evaluate the efficacy, safety and kinetics of Octagam® 10% for replacement therapy in Primary Immunodeficiency Diseases (PID) - NAPrimary Immunodeficiency Diseases (PID)MedDRA version: 9.1Level: LLTClassification code 10064859Term: Primary immunodeficiency syndromeEUCTR2007-002611-27-FROctapharma AG5
进行中（未招募）
不适用
Clinical study to evaluate the efficacy, safety and kinetics of Octagam® 10% for replacement therapy in Primary Immunodeficiency Diseases (PID) - NAPrimary Immundeficiency Diseases (PID)MedDRA version: 9.1Level: LLTClassification code 10064859Term: Primary immunodeficiency syndromeEUCTR2007-002611-27-DEOctapharma AG45
已完成
不适用
Clinical study to evaluate the efficacy, safety and kinetics of Octagam® 10% for replacement therapy in primary immunodeficiency diseasesPrimary immunodeficiency diseases (PID)Haematological DisordersOther immunodeficienciesISRCTN63491981Octapharma AG (Switzerland)45
已完成
2 期
To Find the Effect of LION�S MANE POWDER as Nutritional Supplement.CTRI/2022/03/040724DXN Manufacturing India Pvt Ltd24